GLIMEPIRIDE and VOMITING

Overview

VOMITING is the #10 most commonly reported adverse reaction for GLIMEPIRIDE, manufactured by Lifsa Drugs LLC. There are 1,288 FDA adverse event reports linking GLIMEPIRIDE to VOMITING. This represents approximately 1.9% of all 66,685 adverse event reports for this drug.

Patients taking GLIMEPIRIDE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING is a less commonly reported adverse event for GLIMEPIRIDE, but still significant enough to appear in the safety profile.

Other Side Effects of GLIMEPIRIDE

In addition to vomiting, the following adverse reactions have been reported for GLIMEPIRIDE:

• BLOOD GLUCOSE INCREASED — 2,970 reports
• NAUSEA — 2,275 reports
• DIARRHOEA — 2,170 reports
• DRUG INEFFECTIVE — 1,917 reports
• FATIGUE — 1,829 reports
• HYPOGLYCAEMIA — 1,639 reports
• WEIGHT DECREASED — 1,390 reports
• DIZZINESS — 1,366 reports
• DYSPNOEA — 1,319 reports
• ACUTE KIDNEY INJURY — 1,214 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

Does GLIMEPIRIDE cause VOMITING?

VOMITING has been reported as an adverse event in 1,288 FDA reports for GLIMEPIRIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with GLIMEPIRIDE?

VOMITING accounts for approximately 1.9% of all adverse event reports for GLIMEPIRIDE, making it a notable side effect.

What should I do if I experience VOMITING while taking GLIMEPIRIDE?

If you experience vomiting while taking GLIMEPIRIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages